Pharma & Medical Device Regulation in Brazil

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first … Personalised medicine in Brazil: IP and regulatory challenges

In a tight vote, the Special Committee of the Chamber of Deputies approved this Tuesday, June 8, Bill No. 399/2015 (PL 399/2015), … Special Committee of the Chamber of Deputies approves Bill No. 399/2015, on medical, veterinary and industrial uses of Cannabis

ANVISA’s Board of Directors opened a Public Consultation (“PC 1,039/2021”), available to contributions between 04/15/2021 and 06/15/2021, to discuss a proposed regulation … ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions